ELOVL1 and X-linked adrenoleukodystrophy: This compound was originally developed as a potent and selective ELOVL1 inhibitor in the context of X-linked adrenoleukodystrophy (X-ALD) with well-characterized in vitro and in vivo activities (Fig. 4a)24,25.